Marc Bonneville, DVM, PhD, is a distinguished immunologist renowned for his extensive research in immunology, oncology, and infectious diseases. Dr. Bonneville has held several prominent positions throughout his career, including Director of the INSERM Cancer Research Center in Nantes/Angers and Director of the Pays de la Loire branch of the French Blood Bank. In 1999, he co-founded Innate Pharma, a biotechnology company focused on developing innovative immunotherapies targeting innate lymphocytes in infectious diseases and oncology. In 2013, Dr. Bonneville joined Institut Mérieux as Vice President of Medical and Scientific Affairs. Three years later, in 2016, he was appointed Chairman of the Alliance for Research and Innovation in the Healthcare Industries (ARIIS), an organization affiliated with the French Health Industry Federation (FEFIS) aimed at fostering synergy across various healthcare sectors. Throughout his career, Dr. Bonneville has authored over 200 scientific publications and co-signed multiple patents. His contributions have been recognized with several awards, including the CNRS Bronze and Silver Medals.